Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
75
FHI Quote, Financials, Valuation and Earnings
Last price:
$43.01
Seasonality move
:
1.34%
Day range:
$42.91 - $43.23
52-week range:
$31.24 - $43.92
Dividend yield:
2.96%
P/E ratio:
12.09x
P/S ratio:
2.03x
P/B ratio:
3.16x
Volume:
659.2K
Avg. volume:
911.6K
1-year change:
30.92%
Market cap:
$3.4B
Revenue:
$1.6B
EPS (TTM):
$3.55
Analysts' Opinion
-
Consensus RatingFederated Hermes has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 6 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $42.00, Federated Hermes has an estimated downside of -2.17% from its current price of $42.93.
-
Price Target UpsideAccording to analysts, the highest upside price target is $45.00 representing -100% upside increase from its current price of $42.93.
Fair Value
-
According to the consensus of 7 analysts, Federated Hermes has -2.17% downside to fair value with a price target of $42.00 per share.
FHI vs. S&P 500
-
Over the past 5 trading days, Federated Hermes has underperformed the S&P 500 by -1.21% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Federated Hermes does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Federated Hermes has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Federated Hermes reported revenues of $423.5M.
Earnings Growth
-
Federated Hermes has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Federated Hermes reported earnings per share of $1.25.
Enterprise value:
3.3B
EV / Invested capital:
2.19x
Price / LTM sales:
2.03x
EV / EBIT:
7.67x
EV / Revenue:
1.97x
PEG ratio (5yr expected):
14.19x
EV / Free cash flow:
9.55x
Price / Operating cash flow:
9.86x
Enterprise value / EBITDA:
7.29x
Gross Profit (TTM):
$1.1B
Return On Assets:
14.54%
Net Income Margin (TTM):
17.74%
Return On Equity:
25.83%
Return On Invested Capital:
19.79%
Operating Margin:
31.87%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.6B | $1.7B | $396.4M | $423.5M | |
| Gross Profit | $987.6M | $1.1B | $1.1B | $259.8M | $280.3M | |
| Operating Income | $382.1M | $414.7M | $474M | $101.8M | $135M | |
| EBITDA | $368.1M | $459.9M | $448.5M | $112.8M | $144.6M | |
| Diluted EPS | $2.83 | $3.52 | $3.55 | $0.89 | $1.25 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $520.3M | $581.8M | $636.3M | $719.7M | $678.6M | |
| Total Assets | $2B | $2B | $2B | $2.1B | $2B | |
| Current Liabilities | $199.3M | $181M | $212.2M | $212.5M | $223M | |
| Total Liabilities | $854.8M | $912M | $852.8M | $866.4M | $858.7M | |
| Total Equity | $1.2B | $1.1B | $1.1B | $1.2B | $1.1B | |
| Total Debt | $70M | $397.4M | $347.6M | $347.9M | $348.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $348.6M | $320.4M | $346.8M | $14M | $14.3M | |
| Cash From Investing | -$28M | -$4.9M | $35.1M | $27.6M | -$1.5M | |
| Cash From Financing | -$245.4M | -$284.6M | -$360.4M | -$63.5M | -$137.6M | |
| Free Cash Flow | $345.4M | $312.7M | $342.4M | $13.5M | $13.3M | |
FHI
Sector
Market Cap
$3.4B
$628.1M
Price % of 52-Week High
97.75%
87.3%
Dividend Yield
2.96%
1.97%
Shareholder Yield
12.27%
4.02%
1-Year Price Total Return
30.92%
9.14%
Beta (5-Year)
0.777
0.587
Dividend yield:
2.96%
Annualized payout:
$2.21
Payout ratio:
63.31%
Growth streak:
2 years
Technicals
8-day SMA
Buy
Level
$42.86
200-day SMA
Buy
Level
$38.58
Bollinger Bands (100)
Buy
Level
37.8 - 41.2
Chaikin Money Flow
Buy
Level
40.6M
20-day SMA
Buy
Level
$41.28
Relative Strength Index (RSI14)
Buy
Level
64.88
ADX Line
Buy
Level
24.74
Williams %R
Neutral
Level
-24.0409
50-day SMA
Buy
Level
$39.83
MACD (12, 26)
Buy
Level
1.12
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
92M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.6937)
Buy
CA Score
(Annual)
Level (0.8328)
Buy
Beneish M-Score
(Annual)
Level (-2.7516)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.2947)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Federated Hermes provides asset-management services for institutional and individual investors. The firm had $800 billion in managed assets at the end of September 2024, composed of equity (10%), multi-asset (less than 1%), fixed-income (12%), alternative (3%), and money market (74%) funds. The firm's cash-management operations are expected to generate around 51% of Federated's revenue this year, compared with 29%, 12%, and 7%, respectively, for the equity, fixed-income, and alternatives/multi-asset operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (65% of AUM), institutional investors (26%), and international clients (9%).
Stock Forecast FAQ
In the current month, FHI has received 1 Buy ratings 6 Hold ratings, and 0 Sell ratings. The FHI average analyst price target in the past 3 months is $42.00.
-
Where Will Federated Hermes Stock Be In 1 Year?
According to analysts, the consensus estimate is that Federated Hermes share price will drop to $42.00 per share over the next 12 months.
-
What Do Analysts Say About Federated Hermes?
Analysts are divided on their view about Federated Hermes share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Federated Hermes is a Sell and believe this share price will rise from its current level to $39.00.
-
What Is Federated Hermes's Price Target?
The price target for Federated Hermes over the next 1-year time period is forecast to be $42.00 according to 7 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is FHI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Federated Hermes is a Hold. 6 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of FHI?
You can purchase shares of Federated Hermes via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Federated Hermes shares.
-
What Is The Federated Hermes Share Price Today?
Federated Hermes was last trading at $43.01 per share. This represents the most recent stock quote for Federated Hermes. Yesterday, Federated Hermes closed at $42.93 per share.
-
How To Buy Federated Hermes Stock Online?
In order to purchase Federated Hermes stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is up 2.36% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 21.87% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 12.44% over the past day.
